Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Manoj Monga, MD

216.444.5600

Manoj Monga, MD
Department: Urology
Director, Center for Endourology and Stone Disease
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.8678
WorkFax:216.636.0770
Manoj Monga, MD
Department: Biomedical Engineering
Director, Center for Endourology and Stone Disease
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.8678
WorkFax:216.636.0770
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Dr. Manoj Monga joined Cleveland Clinic's staff in 2010 as Director of the Stevan B. Streem Center for Endourology & Stone Disease. Prior to coming to Cleveland, he was the Joseph Sorkness Family Endowed Professor and Vice-Chair of Urologic Surgery and Director of Endourology & Stone Disease at the University of Minnesota.

Dr. Monga is recognized as an international authority in endourology and stone disease, and has been an invited speaker in India, Thailand, Brazil, Italy, Greece, Mexico, China, United Kingdom and the Netherlands. He has also acted as a Visiting Professor at many of the major medical centers in the United States.

Additionally, Dr. Monga has published more than 250 peer-reviewed manuscripts.

Education & Fellowships

Residency - Tulane University Hospital & Clinics
Urology
New Orleans, LA USA
1997
Research Fellowship - Tulane University Hospital & Clinics
Research
New Orleans, LA USA
1993
Residency - Tulane University Hospital & Clinics
General Surgery
New Orleans, LA USA
1992
Medical School - Chicago Medical School
Chicago, IL USA
1990
Undergraduate - Queen's University
Kingston, Ontario Canada
1986

Certifications

  • Urology

Specialty Interests

Kidney stones, ureteral strictures, ureteropelvic junction (UPJ) obstruction, retroperitoneal fibrosis, kidney (renal) stone disease

Awards & Honors

Dr. Monga is the recipient of several awards, including the Endourology Society's "Arthur Smith Young Innovators' Award" in 2007, and in 2008 he received first prize in the American Urological Association/Gyrus ACMI Essay Contest.

Treatment & Services

  • Urology

Specialty in Diseases and Conditions

  • Kidney Stones
  • Ureteral Strictures
  • Ureteropelvic Junction (UPJ) Obstruction

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/22/2013, Dr. Monga has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Monga receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Bard Urological (a division of C.R. Bard, Inc.)
  • Coloplast A/S
  • Cook Group Incorporated
  • ForTec Litho, LLC
  • Olympus America Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English